Related Experiment Videos
Myofibroblast involvement in chronic transplant rejection
E Pedagogos1, T D Hewitson, R G Walker
1Department of Nephrology, The Royal Melbourne Hospital, Victoria, Australia.
Transplantation
|November 14, 1997
Summary
Myofibroblasts (MF) contribute to chronic kidney transplant rejection by causing pathologic scarring. Increased MF presence and alpha-smooth muscle actin staining correlate with worsening fibrosis in rejected renal allografts.
Area of Science:
- Nephrology
- Transplantation Immunology
- Pathology
Background:
- Chronic rejection is a primary cause of late kidney transplant failure.
- Myofibroblasts (MF) are implicated in fibrotic processes.
- The role of MF in chronic renal allograft rejection requires further elucidation.
Purpose of the Study:
- To investigate the role of myofibroblasts (MF) in the pathogenesis of chronic renal transplant rejection.
- To assess the correlation between MF presence, fibrosis, and time post-transplantation in rejected kidney allografts.
Main Methods:
- Analysis of renal biopsies from 10 patients with chronic rejection at various time points.
- Comparison with control biopsies from patients without rejection.
- Identification of MF via morphology and alpha-smooth muscle actin immunostaining.
- Quantification of T cells, macrophages, and collagen III deposition.
Main Results:
- Significantly increased interstitial fractional area, collagen III, MF, and T-cell staining in rejected kidneys compared to controls.
- Alpha-smooth muscle actin staining intensified over time, correlating with fibrosis and collagen deposition.
Conclusions:
- Myofibroblasts (MF) are a significant component of the interstitial infiltrate in chronic renal transplant rejection.
- Persistent MF accumulation contributes to the pathologic scarring and fibrosis observed in rejected kidney allografts.